Nussbaum Ran bought LBRX
September 10, 2025 · Form 4 insider transaction
Nussbaum Ran bought 22,449 shares of LB Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
22,449
Price
$0.00
Total value
N/A
InsiderNussbaum Ran
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 10, 2025
Filing dateSeptember 12, 2025
Shares owned after22,449
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option award shall vest in three (3) equal annual installments on September 10, 2026, September 10, 2027 and September 10, 2028, subject to the Reporting Person's continuous service through such vesting date.